HIGHLIGHTS
SUMMARY
The knowledge and the promotion of non-oncological RT, thus, could counterbalance the expected loss of patients or RT fractions foregone in the next future due to the use of hypofractionation. Similarly, in the Polish SMART-VT Trial, Kurzelowski et_al used Stereotactic Arrhythmia Radioablation (STAR) for two patients with refractory VT, using the same dose (25 Gy in single fx). Wight et_al, similarly, treated with the same dose 14 patients with refractory VT. Kurzelowski R VT Efficacy and safety of treatment 25 Gy/1 fx No problem in the first patient. Lee J VT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.